Roanoke Asset Management Corp Alkermes Plc. Transaction History

Roanoke Asset Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 29, 2019	SELL	$28.4 - $36.49 $1.59 Million - $2.05 Million	-56,161 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$27.94 - $44.61 $34,226 - $54,647	-1,225 Reduced 2.13%	56,161 $1.66 Million
Q2 2018 Jul 25, 2018	SELL	$40.56 - $51.36 $127,764 - $161,784	-3,150 Reduced 5.2%	57,386 $2.36 Million
Q1 2018 Apr 19, 2018	SELL	$53.61 - $67.26 $110,972 - $139,228	-2,070 Reduced 3.31%	60,536 $3.51 Million
Q4 2017 Jan 29, 2018	SELL	$47.69 - $55.39 $286,855 - $333,170	-6,015 Reduced 8.77%	62,606 $3.43 Million
Q3 2017 Oct 20, 2017	BUY	$49.16 - $54.45 $3.37 Million - $3.74 Million	68,621	68,621 $3.49 Million

349

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.37B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Roanoke Asset Management Corp with notifications on news.